2024 predictions from MM+M Agency 100 honorees
“GenAI made a big splash this year, but we haven’t seen anything yet! As we move into 2024 things will pick up even further. With the U.S. FDA currently recruiting new advisors to oversee AI regulations across life science interventions, we’ll soon witness the introduction of new models for providing medical care, new products, and solutions only now being imagined.”
Matt Lewis, Chief AI Officer at Inizio Medical, has recently shared his forecasts for Generative AI in 2024 in an article published by Medical Marketing and Media (MM+M). The article examines insights and predictions from various MM+M honorees regarding the future of AI.
For the full compilation of predictions read the article on the MM+M website: MM+M
Jump to a slide with the slide dots.
AI’s transformative influence on medical communications
Discover AI's impact on medical communications, aiding HCPs with complex data and patient care. Download our eBook to learn more.
Read moreInizio Medical Issues Urgent Call to Action for AI Adoption in HCA statement
A newly published AI roadmap, co-authored by the Healthcare Communications Association (HCA) and Inizio Medical’s...
Read moreBiotech medical affairs roundtable: Omnichannel engagement
Part one of our biotech discussion series, featuring experts from Inizio Medical, focused on 2024 trends in the medical...
Read moreBiotech medical affairs roundtable: Trends in 2024
Responsible for evidence generation, medical education, publications, and medical communications, medical affairs is...
Read more